Design, synthesis, and biological evaluation of a biyouyanagin compound library

Proceedings of the National Academy of Sciences of the United States of America

Volumn 108, Issue 17, 2011, Pages 6715-6720

  Nicolaou, K C ^a,b   Sanchini, Silvano ^a   Sarlah, David ^a   Lu, Gang ^a   Wu, T Robert ^a   Nomura, Daniel K ^a   Cravatt, Benjamin F ^a   Cubitt, Beatrice ^a   De La Torre, Juan C ^a   Hessell, Ann J ^a   Burton, Dennis R ^a,c  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

2 + 2 photocycloaddition; Anti inflammatory agents; Antiviral agents

Indexed keywords

BIYOUYANAGIN A; BIYOUYANAGIN B; HYPERICUM EXTRACT; NATURAL PRODUCT; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; ANTIVIRAL ACTIVITY; ARENAVIRUS; ARTICLE; CONTROLLED STUDY; DRUG DESIGN; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HYPERICUM; NONHUMAN; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

ANTI-HIV AGENTS; ARENAVIRIDAE INFECTIONS; ARENAVIRUS; CELL LINE; HIV; HIV INFECTIONS; HUMANS; MOLECULAR STRUCTURE; SESQUITERPENES; SPIRO COMPOUNDS;

ARENAVIRUS;

EID: 79955551140     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1015258108     Document Type: Article

References (37)

1. Newman DJ, Cragg GM (2007) Natural products as sources of new drugs over the last 25 years. J Nat Prod 70:461-477. (Pubitemid 46595760)
2. Cragg GM, Newman DJ, Snader KM (1997) Natural products in drug discovery and development. J Nat Prod 60:52-60. (Pubitemid 27052102)
3. Nicolaou KC, Chen JS, Dalby SM (2009) From nature to the laboratory and into the clinic. Bioorg Med Chem 17:2290-2303.
4. Nicolaou KC, Montagnon T (2008) Molecules that Changed the World (Wiley-VCH, Weinheim, Germany) p 366.
5. Carter PJ (2006) Potent antibody therapeutics by design. Nat Rev Immunol 6:343-357.
6. Reichert JM, Rosensweig CJ, Faden LB, Dewitz MC (2005) Monoclonal antibody successes in the clinic. Nat Biotechnol 23:1073-1078. (Pubitemid 41486385)
7. Waldmann TA (2003) Immunotherapy: Past, present and future. Nat Med 9:269-277.
8. Scott CT (2005) The problem with potency. Nat Biotechnol 23:1037-1039.
9. Carter P (2001) Improving the efficacy of antibody-based cancer therapies. Nat Rev Cancer 1:118-129.
10. Glennie MJ, Johnson PW (2000) Clinical trials of antibody therapy. Immunol Today 21:403-410. (Pubitemid 30612302)
11. Hinterding K, Alonso-Díaz D, Waldmann H (1998) Organic synthesis and biological signal transduction. Angew Chem Int Edit 37:688-749. (Pubitemid 28214071)
12. Hung DT, Jamison TF, Schreiber SL (1996) Understanding and controlling the cell cycle with natural products. Chem Biol 3:623-639. (Pubitemid 26351772)
13. Burke MD, Schreiber SL (2003) A planning strategy for diversity-oriented synthesis. Angew Chem Int Edit 43:46-58. (Pubitemid 38063470)
14. Schreiber SL (2000) Target-oriented and diversity-oriented organic synthesis in drug discovery. Science 287:1964-1969.
15. Burke MD, Berger EM, Schreiber SL (2003) Generating diverse skeletons of small molecules combinatorially. Science 302:613-618. (Pubitemid 37310911)
16. Nicolaou KC, et al. (2000) Natural product-like combinatorial libraries based on privileged structures. 1. General principles and solid-phase synthesis of benzopyrans. J Am Chem Soc 122:9939-9953.
17. Nicolaou KC, et al. (2009) Total synthesis and biological evaluation of cortistatins A and J and analogues thereof. J Am Chem Soc 131:10587-10597.
18. Nicolaou KC, Roschangar F, Vourloumis D (1998) Chemical biology of epothilones. Angew Chem Int Edit 37:2014-2045. (Pubitemid 28397935)
19. Nicolaou KC (2005) Endeavors in chemical biology and medicinal chemistry. J Med Chem 48:5613-5638.
20. Cee VJ, Chen DY-K, Lee MR, Nicolaou KC (2009) Cortistatin A is a high-affinity ligand of protein kinases ROCK, CDK8, and CDK11. Angew Chem Int Edit 47:8952-8957.
21. Schulz V (2002) Clinical trials with Hypericum extracts in patients with depression- Results, comparisons, conclusions for therapy with antidepressant drugs. Phytomedicine 9:468-474.
22. Tanaka N, et al. (2005) Biyouyanagin A, an anti-HIV agent from Hypericum chinense L var. salicifolium. Org Lett 7:2997-2999. (Pubitemid 40992616)
23. Tanaka N, et al. (2009) Acylphloroglucinol, biyouyanagiol, biyouyanagin B, and related spiro-lactones from Hypericum chinense. J Nat Prod 72:1447-1452.
24. Nicolaou KC, Sarlah D, Shaw DM (2007) Total synthesis and revised structure of biyouyanagin A. Angew Chem Int Edit 46:4708-4711. (Pubitemid 46997467)
25. Nicolaou KC, et al. (2008) Total synthesis, revised structure, and biological evaluation of biyouyanagin A and analogues thereof. J Am Chem Soc 130:11114-11121.
26. Nicolaou KC, Sanchini S, Wu TR, Sarlah D (2010) Total synthesis and structural revision of biyouyanagin B. Chem Eur J 16:7678-7682.
27. Aramaki Y, Chiba K, TadaM(1995) Spiro-lactones, hyperolactone A-D from Hypericum chinense. Phytochemistry 38:1419-1421.
28. Buchmeier M, Peters CJ, de la Torre JC (2007) Fields Virology, ed DM Knipe (Lippincott Williams & Wilkins, Philadelphia), 5th Ed,, pp 1792-1827.
29. Barton LL, Mets MB, Beauchamp CL (2002) Lymphocytic choriomeningitis virus: Emerging fetal teratogen. Am J Obstet Gynecol 187:1715-1716. (Pubitemid 36026714)
30. Peters C (2006) Lymphocytic choriomeningitis virus-An old enemy up to new tricks. New Engl J Med 345:2208-2211.
31. Borio L, et al. (2002) Hemorrhagic fever viruses as biological weapons: Medical and public health management. J Am Med Assoc 287:2391-2405. (Pubitemid 34493202)
32. Emonet SF, Garidou L, McGavern DB, de la Torre JC (2009) Generation of recombinant lymphocytic choriomeningitis viruses with trisegmented genomes stably expressing two additional genes of interest. Proc Natl Acad Sci USA 106:3473-3478.
33. Glass CK, Saijo K, Winner B, Marchetto MC, Gage FH (2010) Mechanisms underlying inflammation in neurodegeneration. Cell 140:918-934.
34. Medzhitov R (2008) Origin and physiological roles of inflammation. Nature 454:428-435.
35. Grivennikov SI, Greten FR, Karin M (2010) Immunity, inflammation, and cancer. Cell 140:883-899.
36. Hotamisligil GS (2010) Endoplasmic reticulum stress and the inflammatory basis of metabolic disease. Cell 140:900-917.
37. Dinarello CA (2010) Anti-inflammatory agents: Present and future. Cell 140:935-950.